PGBioclin SRL

PGBioclin reported total assets of 208,043 € at the end of the 2025 financial year (annual accounts filed with the NBB on 19 Mar 2026).

Company number (CBE) 0747.635.715 · VAT BE0747635715
4834 Limbourg
active in Research and experimental development on other natural sciences and engineering (NACE 72109)
operating since 26 May 2020 (≈ 6 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of PGBioclin shows with a free account.

See the score
Profile
SRL since 2020
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result90,119 €
Equity5,495 €
Cash3,682 €
EBITDA132,142 €
Total assets208,043 €
Solvency2.6%
The line marks its sector median: 58.2% (260 companies).

Change 2022 → 2025: Equity -98 % Total assets -46 %

Accounts of the company itself (not consolidated).

The full file covers 6 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

PGBioclin's annual accounts

20252024202320222021
Net result90,119 €
Equity5,495 €
Cash3,682 €
EBITDA132,142 €
Total assets208,043 €

Filed annual accounts

  • Year ended 31 Dec 2025filed on 19 Mar 2026
  • Year ended 31 Dec 2024filed on 01 Apr 2025
  • Year ended 31 Dec 2023filed on 13 Mar 2024
  • Year ended 31 Dec 2022filed on 12 Apr 2023
  • Year ended 31 Dec 2021filed on 20 Apr 2022

PGBioclin's financial analysis

Management and control of PGBioclin

1 active director(s) in the register.

PGBioclin's shareholders and holdings →

PGBioclin's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0747.635.715
VAT number
BE0747635715
Peppol
Not found on Peppol as of 10 Nov 2026 · Check
Legal form
SRL
Incorporated
26 May 2020
Registered office
4834 Limbourg
Latest accounts
2025 · filed on 19 Mar 2026
Activity
Research and experimental development on other natural sciences and engineering (NACE 72109)

PGBioclin (SRL) has been based in Limbourg since 2020, active in: research and experimental development on other natural sciences and engineering. For 2025, it reports a net profit of 90,119 € and equity of 5,495 €; its revenue is not published. Its solvency stands at 2.6%, below the median of its sector (58.2%).

Companies similar to PGBioclin

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about PGBioclin

What is the revenue of PGBioclin?

PGBioclin files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of PGBioclin?

In Belgium, the VAT number is the company number prefixed with BE: BE0747635715 for PGBioclin, if the company is VAT-registered. Its company number (CBE) is 0747.635.715.

Where is the registered office of PGBioclin?

According to the CBE register, the registered office of PGBioclin is in 4834 Limbourg.

What is the equity of PGBioclin?

At the close of the 2025 financial year, the equity of PGBioclin amounts to 5,495 €, a solvency of 2.6% of total assets.

Who manages PGBioclin?

The register lists 1 active mandates at PGBioclin. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of PGBioclin

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 08 Aug 2026

No credit card, no commitment.

What each plan unlocks →